Upgrade to SI Premium - Free Trial

FDA approves Lilly's Inluriyo combo with Verzenio for breast cancer

September 18, 2026 1:54 PM
Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration has granted full approval to Inluriyo ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA